Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM04646 Inhalation Solution in Idiopathic Pulmonary Fibrosis
NCT03591926Phase 2Withdrawn
- Sponsor
- Biosplice Therapeutics
- Start
- Jan 1900
- Primary completion
- Jan 1900
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of SM04646 in idiopathic pulmonary fibrosis (IPF), sponsored by Biosplice Therapeutics. Planned start Jan 1900; status: withdrawn.
02
Drugs
SM04646
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT03591926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591926.